These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27942780)

  • 61. Assessing the impact of complications on the costs of Type II diabetes.
    Williams R; Van Gaal L; Lucioni C;
    Diabetologia; 2002 Jul; 45(7):S13-7. PubMed ID: 12136406
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The progressive cost of complications in type 2 diabetes mellitus.
    Brown JB; Pedula KL; Bakst AW
    Arch Intern Med; 1999 Sep; 159(16):1873-80. PubMed ID: 10493317
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.
    Diabetes Care; 1999 Jul; 22(7):1125-36. PubMed ID: 10388978
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire.
    Shen W; Kotsanos JG; Huster WJ; Mathias SD; Andrejasich CM; Patrick DL
    Med Care; 1999 Apr; 37(4 Suppl Lilly):AS45-66. PubMed ID: 10217393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quality of life following a change in therapy for diabetes mellitus.
    Pibernik-Okanović M; Szabo S; Metelko Z
    Pharmacoeconomics; 1998 Aug; 14(2):201-7. PubMed ID: 10186460
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-effectiveness of diabetes education.
    Assal JP
    Pharmacoeconomics; 1995; 8 Suppl 1():68-71. PubMed ID: 10159008
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Type II diabetes and quality of life: a review of the literature.
    Hörnquist JO; Wikby A; Stenström U; Andersson PO; Akerlind I
    Pharmacoeconomics; 1995; 8 Suppl 1():12-6. PubMed ID: 10158997
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lowering the risk of visual impairment and blindness.
    Cunha-Vaz J
    Diabet Med; 1998; 15 Suppl 4():S47-50. PubMed ID: 9868992
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.
    King H; Aubert RE; Herman WH
    Diabetes Care; 1998 Sep; 21(9):1414-31. PubMed ID: 9727886
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Variations in population health status: results from a United Kingdom national questionnaire survey.
    Kind P; Dolan P; Gudex C; Williams A
    BMJ; 1998 Mar; 316(7133):736-41. PubMed ID: 9529408
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis.
    Hermann BP; Vickrey B; Hays RD; Cramer J; Devinsky O; Meador K; Perrine K; Myers LW; Ellison GW
    Epilepsy Res; 1996 Oct; 25(2):113-8. PubMed ID: 8884169
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The psychological care of patients with insulin-dependent diabetes mellitus.
    Jacobson AM
    N Engl J Med; 1996 May; 334(19):1249-53. PubMed ID: 8606721
    [No Abstract]   [Full Text] [Related]  

  • 73. Assessment of quality-of-life outcomes.
    Testa MA; Simonson DC
    N Engl J Med; 1996 Mar; 334(13):835-40. PubMed ID: 8596551
    [No Abstract]   [Full Text] [Related]  

  • 74. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study.
    Kumar S; Ashe HA; Parnell LN; Fernando DJ; Tsigos C; Young RJ; Ward JD; Boulton AJ
    Diabet Med; 1994 Jun; 11(5):480-4. PubMed ID: 8088127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The economic costs of non-insulin-dependent diabetes mellitus.
    Huse DM; Oster G; Killen AR; Lacey MJ; Colditz GA
    JAMA; 1989 Nov; 262(19):2708-13. PubMed ID: 2509743
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of functional impairment and social support on depressive symptoms in persons with diabetes.
    Littlefield CH; Rodin GM; Murray MA; Craven JL
    Health Psychol; 1990; 9(6):737-49. PubMed ID: 2286183
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Major developments in behavioral diabetes research.
    Cox DJ; Gonder-Frederick L
    J Consult Clin Psychol; 1992 Aug; 60(4):628-38. PubMed ID: 1506511
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Coping with Type II diabetes: the patient's perspective.
    Koopmanschap M
    Diabetologia; 2002 Jul; 45(Suppl 1):S21-S22. PubMed ID: 27942780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.